Edition:
United Kingdom

Mithra Pharmaceuticals SA (MITRA.BR)

MITRA.BR on Brussels Stock Exchange

18.56EUR
23 Feb 2018
Change (% chg)

€1.06 (+6.06%)
Prev Close
€17.50
Open
€17.60
Day's High
€18.58
Day's Low
€17.60
Volume
196,816
Avg. Vol
64,080
52-wk High
€18.58
52-wk Low
€8.41

Chart for

About

Mithra Pharmaceuticals SA is a Belgium-based company that provides pharmaceutical services. It was founded in 1999.

Overall

Beta: --
Market Cap(Mil.): €351.67
Shares Outstanding(Mil.): 34.24
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 31.10 16.60
EPS (TTM): -- -- --
ROI: -- 14.91 10.66
ROE: -- 16.41 14.30

BRIEF-Mithra Announces Very Promising Hemostasis Results For Estelle​

* ‍MITHRA PHARMACEUTICALS SA - MITHRA ANNOUNCES VERY PROMISING HEMOSTASIS RESULTS FOR ESTELLE®​

08 Feb 2018

BRIEF-Mithra Pharmaceuticals Announces Last Subject Completes Donesta Phase II Study​

* ‍MITHRA ANNOUNCES LAST SUBJECT COMPLETES DONESTA® PHASE II STUDY​

25 Jan 2018

BRIEF-Mithra Pharmaceuticals And Adamed Sign Commercialization Agreement For Myring™ In The Czech Republic

* MITHRA AND ADAMED SIGN COMMERCIALIZATION AGREEMENT FOR MYRING™ IN THE CZECH REPUBLIC

27 Dec 2017

BRIEF-Mithra Pharmaceuticals Announces Injectables Agreement With GSP

* MITHRA CLOSES CONTRACTS WITH LEADING GENERICS PLAYER GSP FOR DEVELOPMENT AND SUPPLY OF 4 HORMONAL INJECTABLES

14 Dec 2017

BRIEF-Mithra Pharmaceuticals Finalizes Estelle Contract With Libbs

* FINALIZES ESTELLE CONTRACT WITH BRAZILIAN WOMEN’S HEALTH LEADER LIBBS

11 Dec 2017

BRIEF-Mithra Announces Valorization Of French Subsidiary

* SUCCESSFULLY DIVESTED ITS FRENCH AFFILIATE, MITHRA FRANCE‍​

07 Dec 2017

BRIEF-Mithra Pharmaceuticals Announces Update On Clinical Study Progress For Estelle And Donesta‍​

* ANNOUNCES AN UPDATE ON THE CLINICAL STUDY PROGRESS FOR ESTELLE AND DONESTA‍​

30 Nov 2017

BRIEF-Mithra Pharmaceuticals announces 36-month shelf life extension for Tibelia​

* ‍MITHRA ANNOUNCES 36-MONTH SHELF LIFE EXTENSION FOR TIBELIA​

22 Nov 2017

BRIEF-Mithra Pharmaceuticals: ‍positive outcome of Myring commercial batch bioequivalence study​

* ‍POSITIVE OUTCOME OF MYRING COMMERCIAL BATCH BIOEQUIVALENCE STUDY

17 Nov 2017

BRIEF-Mithra Pharmaceuticals ‍completes recruitment for Estelle Phase III study in US and Canada​

* ‍COMPLETES RECRUITMENT FOR ESTELLE® PHASE III STUDY IN US AND CANADA​

30 Oct 2017

Earnings vs. Estimates